chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse practitioner concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, dose and route not reported). The nurse noted hearing "via word-of-mouth" of the patient in another clinic experienced shingles. Attempts are being made to verify the existence of an identifiable patient. Follow-up information has been received via telephone call, from a nurse practitioner, concerning a patient who, on an unknown date received a dose of ZOSTAVAX (Merck) (Lot #, dose and route not reported). The nurse practitioner stated that the patient received the ZOSTAVAX (Merck) at another take care clinic. She also stated that the patient developed shingles after receiving the ZOSTAVAX (Merck). At the time of the report the patient's outcome was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
Had Pfizer for initial 2 doses with Moderna as a booster 6 months later than 2nd Pfizer shot.  Dizziness, stumbling,  headache, chest discomfort, eyes felt funny and off balance.  Very strong for 6+ hours then slightly still affecting me 2 days later especially the off balance dizziness part.
She got the shot yesterday at 5pm. She woke up this morning at 6 am feeling awful. Around 1pm today the school called me to pick her up. She was running a low grade temp and feeling worse. Around 6pm this evening her fever is 102.4, shes ubable to walk. She says she can feel her legs but when she tried to stand she felt like she had nothing ubder her to support her weight. Kind of like her legs weren't there. When she sits up, her head hurts so bad it brings tears to her eyes. We haven't done anything yet as im not sure what to do.
Itching; This case was reported by a consumer via call center representative and described the occurrence of itchy upper limbs in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 24th August 2019, 2 days after receiving Shingrix, the patient experienced itchy upper limbs. The patient was treated with hydrocortisone (Hydrocortisone Cream). On an unknown date, the outcome of the itchy upper limbs was unknown.   It was unknown if the reporter considered the itchy upper limbs to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on left arm. The patient experienced itching on the front of the right arm closer to her shoulder. On the reporting date, the patient's left arm had started to itch closer to her shoulder.  The itching felt like stabbing 2 inches deep into the skin.  The itching was like poison oak and felt like a lightning bolt. Due to increased scratching, the patient had started tobleed.  The patient had used hydrocortisone cream and it did not help.  The patient had applied band aid over her area where she was bleeding.  The reporter did not consent to follow-up.  No further details were provided.
2 days after the 1st dose, my right shoulder joint became very painful. The symptoms have been worsening every day for over 3 weeks. I have an appointment with my doctor next week, however my appointment for the 2nd shot is Friday 3/19/2021
MORNING OF 2/17/21, DEVELOPED WEAKNESS, AND INABILITY TO STAND. GENERALIZED BODY ACHES AND PAIN, AND CONFUSION. WAS TRANSPORTED TO THE ER AND ADMITTED TO THE HOSPITAL.
My right index finger been swollen; joints very painful; Mild headache; This is a spontaneous report from a non-contactable consumer . A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 26Jul2021 (Batch/Lot Number: EW0180) as single dose for covid-19 immunisation.  The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient experienced her right index finger been swollen and the joints very painful and she has also experienced mild headache and she was scheduled to take second dose and she was very hesitating about taking the second dose because I have been experiencing these symptoms from I believe the first dose so, I am questioning whether or not I should be taking the second dose. The outcome was unknown.  No follow-up attempts are possible. No further information is expected.
Numb tingly fi gers, turn white without known reason. Skin peeling on all fingertips
patient scheduled for dose # 1 Pfizer vaccine. Consent signed by parent. noting no previous covid vaccines. during discussion no mention of previous vaccine in our immunization section no covid vaccines documented. gave vaccine. presented covid vaccine card to parent parent stated patient already had a card.  Looked at card it was noted that patient received 2 doses of pfizer vaccine at a pharmacy. spoke with parent that due to child's age a third dose was not recommended. observed patient for 30 minutes. did a follow up call 24 hours later. no adverse symptoms noted. Provider informed at time of occurrence
I developed a swelling in left armpit, like a big bulge. Told to come in 3 weeks if the lump does not go down. The lump went down in about two, give or take.
Passed out - taken by ambulance to the ER where it was determined I was in A-FIB.  IV fluids and put on a beta blocker.
p/vax a varicella antibody titer was negative;5NOV96 pt presented w/three vesicular pox on arm;By 10NOV96 pt had approx 30 pox;seen by dermatologist tx w/med;results of testing revealed herpes virus;erythematous papular vesicular lesion;
PARENT STATES RASH TO FACE, NECK, CHEST, LEGS OF CHILD. PARENT STATES FEVER ON 9/19/2011 WHICH ENDED 9/20/11. PARENT STATES INJECTION SITE AREAS ARE WARM TO TOUCH. PARENT STATES CHILD SCRATCHES AT RASH.
Patient reported bruising and purple color of vaccinated arm from wrist to shoulder day of vaccination, still has purple. Face on left side gets hot and burns approximately five times daily starting the morning after vaccination and continues today. Patient has seen multiple doctors.
They kept me for observation for 30 minutes due to my clam allergy. 40 minutes post vaccine, I was leaning against the wall waiting for the bathroom when my feet started tingling  up to my ankles, I got light headed and was trying to decide if I should sit on the floor when 2 nurses came by. I stopped them for help. One went for help and the other helped me to the floor. My B/P was 218/100. They wheeled me to the ER where they did their thing. After 4 hours of observation, the PA asked me how I felt, better, and if I could get out of the wheelchair and walk around. I did feel better. I was able to go home. Blood pressure was up until Monday when it came back down into the 130's.  I met another man there who had the same symptoms, but he was tingley  to the top of his head. He said there was also another woman there who had the same symptoms as him.
Fatigue, nausea, joint aches, headache, lasting approximately 1.5 days
Arm got red and very swollen. Redness extended to back and top of chest. Also got painful.
Not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling well) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Not feeling well). On 08-Mar-2021, FEELING ABNORMAL (Not feeling well) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter . Treatment Medications  were not provided by the reporter.
Information has been received from a Licensed Practical Nurse concerning an 81 year old female patient with no pertinent medical history and no known drug reactions or allergies, who on 24-MAY-2012 was vaccinated with a dose of PNEUMOVAX 23, 0.5ml, intramuscularly, (lot number 672394/1853AA, expiry date: 09-AUG-2013). Concomitant therapy included cephalexin, cyanocobalamin, Hydrocodone/APAP, DIOVAN, metoprolol, LIPITOR, promethazine, NAMENDA, VESICARE, alendronate sodium (manufacturer unspecified), diltiazem HCL, metformin, PLAVIX and amiodarone. It was reported that, on 24-MAY-2012, the patient developed injection site reaction after receiving a dose of PNEUMOVAX 23. The painful red swollen area spread down from the injection site area to the patient's elbow. The patient sought medical attention (saw the physician). No treatment was given for the symptoms. No laboratory studies were performed. At the time of the report, the patient's outcome was recovering. This is the first of three cases reported by the nurse. Other two reports are: WAES#1206USA00496 and WAES# 1206USA00486. The reporter requested a lot check of this vaccine due to patients having adverse experiences. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the agency and was released. Additional information has been requested.
Information has been received from a pharmacist concerning a 59 year old female patient with Parkinson's disease and no allergies who on 22-MAY-2007 was vaccinated SC with 0.65 ml dose of Zostavax. On approximately 22-MAY-2007, the patient experienced pain, redness, swelling and bruising at injection site. It was reported that patient also experienced dizziness. Unspecified medical attention was sought. No diagnostic laboratory tests were undertaken. At the time of report the patient was not recovered. A product quality complaint was not involved. Additional information has been requested. 09/24/07 This is in follow-up to report(s) previously submitted on 6/14/2007. Additional information has been received from the pharmacist who stated that on the day of vaccination the patient developed swelling and soreness on arm. The patient recovered 5 days after vaccination. No further information is expected.
Patient was mistakenly administered 5th dose of COVID vaccine. He has his 4th dose on 4/11/22, but staff were unaware of this and patient forgot. A 5th dose was administered on 5/25/22. No adverse reactions reported. No treatments were given.
Chills 10 hrs after injection which became much worse through the next day. Approximately 24 hours after injection my fever increased to 102.7 despite taking ibuprofen.
Fever with "body twitching" that began around 5pm & lasted appx 8 hours. Twitching not rhythmic and present for duration of the entire 8 hour period. Mom concerned w/seizure activity d/t hx.
Discomfort in right upper arm right away. More discomfort 3 days later with swelling and red. Muscle tightness in right shoulder, neck pain and occipital headache. Treatment: Tylenol, Anti-inflammation and heating pad.
No additional adverse effects reported; administered an improperly stored dose ofROTATEQ; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 01-SEP-2020, the patient was administered a dose of inappropriately stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (orally, lot # S038691, expiration date 12-MAY-2021 (also reported as 20-MAY-2021) (dose number not reported.) No additional adverse effects reported.  The reported temperature excursion was below "36 degree of Fahrenheit: 35 degree of Fahrenheit" through 20 minutes. There was no previous temperature excursion. The temperature excursions were detected by a Data Logger.
I had hives appear on both right and left shoulders. The inflammations where very itchy and stayed inflamed for two weeks and continues to itch even today.
Headache and 38 C fever two weeks after getting the first dose; Headache and 38 C fever two weeks after getting the first dose; This is a spontaneous report from a contactable physician (patient). A 44-year-old female patient received first dose of BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN 6206) via an unspecified route of administration on 13Mar2021 09:00 AM at single dose in left arm for COVID-19 immunisation. Medical history was reported as none. Patient was not pregnant at the time of vaccination. Concomitant medication was not reported. The patient does not have any allergies to medications, food, or other products. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 04:00 PM, the patient had headache, fever 38 C two weeks after getting vaccinated with first dose. The patient received paracetamol for the treatment of the above events. The outcome of the events was not recovered  No follow-up attempts are needed. No further information is expected.
Started with Severe headache swelling tongue, throat,  throbbing behind eyeballs,  Swelling from ear to ear Chills, trouble breathing Blood clot behind knee (1st ever) Heart racing 2 days feeling like I couldn?t get out of bed 4th day still had swelling & headache but able to take a shower & eat
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 02-APR-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml, (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree. The total cumulative excursion time of the second time was 24 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 61-year-old female patient who received SHINGRIX for prophylaxis. On 21st January 2019, the patient received the 1st dose of SHINGRIX. In January 2019, less than a week after receiving SHINGRIX, the patient experienced tiredness, sweating, pain in arm, chills and sleep excessive. On 21st January 2019, the patient experienced headache. On 23rd January 2019, the patient experienced presyncope. The patient was treated with TYLENOL. On an unknown date, the outcome of the headache, tiredness, sweating, pain in arm, chills, sleep excessive and presyncope were recovered/resolved. It was unknown if the reporter considered the headache, tiredness, sweating, pain in arm, chills, sleep excessive and presyncope to be related to SHINGRIX. Additional details were provided as follows: The patient had a headache towards the evening around 9 PM. After that she experienced tiredness, sweating, fatigue, sore arm and chills. Later she took TYLENOL and slept a lot. The patient tried to get to work on Wednesday and she took a shower and 2 days after receiving SHINGRIX she almost passed out. The symptoms lasted for 3 to 4 days except sore arm which lasted for 7 to 8 days.
Fever 103.0 F Day 7 06/30/2014. Rash 07/02/2014. Diarrhea x 1 episode 06/30/2014 (day 7). Treated with Acetaminophen and Ibuprofen.
Information has been received from a nurse referring to unspecified patients of unknown age and gender. The patients' concurrent condition and medical history were not reported. The concomitant therapy included sterile diluent (manufacturer unknown). The patients received improperly stored doses of PEDVAXHIB (dose, frequency and route were unknown, lot # N000235, expiration date: 26-OCT-2019, lot # N003537, expiration date: 17-NOV-2019, lot # L014426, expiration date: 08-MAR-2018, lot # L004740, expiration date: 16-NOV-2017) for prophylaxis on multiple unknown dates between 01-JAN-2017 to 01-AUG-2017. The temperature excursion was at 32 Fahrenheit Degree to 35 Fahrenheit Degree for 24 hours and 47 Fahrenheit Degree to 77 Fahrenheit Degree for 32 hours. The previous temperature excursion was reported as yes. Data logger was not involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA008435: US-009507513-1709USA008436: US-009507513-1709USA008434.
Received Tdap (Boostrix) and Menactra on the 18th of August. Within 24 hours she started to c/o headaches - "very sharp, uncomfortable" which would come and go throughout the day, sometimes very short lasting, other times lasting an hour or so.  She then developed eye swelling around the 21st.  She had some pain around her eyes, but no associated sinus/nasal congestion, rhinorrhea, fever or chills but her sister was sick with URI and thought she  Might have sinusitis so prescribed Omnicef which she took for 2 weeks.  During that time she continued to have headaches and eye swelling.  She took NSAIDS, tylenol w/o relief of her headaches.   Went to ER on the 26th, given toradol and compazine which was significantly helpful for her headaches.   She was then prescribed Nasonex which also did not help her sx.   She was seen by ENT on the 5th of September, got a sinus x-ray and prescribed prednisone and her eye symptoms, headaches gradually resolved.   She was told she did not have any evidence of a sinus infection.  She finished the steroids on the 9th or 10th of September.  She has some slight swelling around her eyes in the morning which improves as the day goes on.  She has not had any further headaches. Mom states that patient has had changes in short term memory, to include has been forgetting some things recently, such as bringing her homework from school, or putting things away at home which is quite atypical for her. She has gotten D's in spelling, science when she'd normally get straight A's.  Symptoms have gradually improved over 6 weeks, but not entirely resolved.
This spontaneous report was received from an office manager refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reaction and concomitant medications were not reported. On an unspecified date, the patient was administered an improperly stored dose of ROTATEQ (lot # R013288 and expiry date 12-DEC-2019) for prophylaxis (dosing details not reported). The product was kept above 10.04 degree Celsius for more than 5.1 hours). Temperature and Time frame: Total Time and highest temperature above 47 degree F/9 degree C (10.04 C) for 5.1 for hours. Previous temperature excursion: Total Time and lowest temperature below36 degree F/2 degree C (0.6 C) for 8.25 hours. It was reported that digital "data logger" was not involved. Product quality complaint was not involved.
10 days after first injection left arm injection site  was itchy, extremely hot, red and hard.  2 days later the reaction was gone.  3 days later the same thing happened and continues to on April 30.
Pt reported redness and heat at injection site and several weeks later reports shingles outbreak on one side of her back.
One week after injection arm became itchy at injection site. It started it a half dollar size rash, that has now doubled in size. The area is firm and itchy. Not really any pain.
On June 27th, I started feeling like I had allergies. I tested for COVID-19 that day and was negative. Same for Tuesday, June 28th. I felt like I had more allergies. I tested again and was negative. Wednesday, June 29th, I was getting tired and a little more congested. That evening, I tested positive. From there, it became a sore throat, laryngitis and a lot of nasal congestion. I contacted my doctor on July 3rd because I was dealing with asthma. It wouldn't leave my chest. She renewed my inhaler and prescribed SYMBICORT.
aches after second dose; headaches after second dose; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (aches after second dose) and HEADACHE (headaches after second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (aches after second dose) and HEADACHE (headaches after second dose). At the time of the report, MYALGIA (aches after second dose) and HEADACHE (headaches after second dose) outcome was unknown.            No concomitant medication and treatment information was reported.
Extreme swelling in my arm, red rash, itchy skin, ear pain in both ears, cold/flu symptoms
Pt vaccinated with DTP/MMR developed blotchy red rash, w/edema on both upper arms, immediately following administration of immunizations. Ice applied. rash on lt arm cleared in 30 min., rt arm rash decreased.
Covid vaccine monitoring documentation. PT Admitted 6/7/21. POC SARS COV2 ANTIGEN resulted positive 6/7/21 for COVID. PT documented to have had Janssen covid vaccine administered 5/13/21 Lot 204A21A.
Information has been received from a physician concerning a female patient who on 17-MAY-2007 was vaccinated with a first dose of GARDASIL (lot # 657736/0389U) and on 19-JUL-2008 she was vaccinated with a second dose of GARDASIL (lot # 658222/0927U).  On 19-NOV-2007 she was vaccinated IM with a third dose 0.5 mL of GARDASIL (lot # 659439/1267).  The physician reported that on approximately one month after the third injection the patient experienced redness, swelling and warmth at the site of the GARDASIL administration.  The patient sought medical attention from the physician.  At the time of this report the patient had not recovered.  Additional information has been requested.
Pt experienced shortness of breath, weakness, sweating, these began the evening of the vax. Went to bed at 9:30 PM. Woke up fine next morning, no rash and no other problems.
After 3 days started feeling more arm pain. Than what I initially felt at time of vaccine. Now it?s even more sore and have difficulty lifting things . Feels like I worked out my left arm at the gym got 2 days straight.
Swelling, redness, burning, and moderate pain at injection site that has intensified since injection (9 days so far).
presents to the office for an acute care visit. Pt is c/o redness/swelling around injection site. Of note, pt was seen last week-7/3/19 by another provider in the office for annual wellness exam. She notes receiving Prevnar 13 immunization. Within a couple days pt noted development of redness, swelling, and warmth around the site. Pt aware that it is not uncommon for some redness/swelling to occur. However, she has noticed the redness spreading and remaining persistent. She notes associated warmth, tenderness to touch. She denies any associated fevers, chills, myalgias, chest pain, SOB, abd pain, N/V. She has not been taking anything OTC for her sxs.
The patient experienced syncope from a standing position approximately 5 minutes after receiving the Pfizer 1st dose. The patient quickly regained consciousness.  Upon examination the patient did not show any damage to their head, but had bitten their lip.  The patient was position with their back on the ground and feet in the air for approximately 5 minuets. After that the patient was seated in a chair and reported blurry vision that returned to normal.
Fever, migraine, lump at injection site (golf ball size), pain lasted 5 days. Started the day after the shot.
Pt presented to ER with SOB on 01-29-2021. He was admitted to Healthcare with acute CHF exacerbation, elevated lactate, anemia and elevated d-dimer. Pt reports getting SOB getting up to go to the bathroom.  Pt was intubated. He developed pulmonary edema. Pt expired on 02-02-2021 at 10:13 PM.